Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy : An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Hodgson, Robert orcid.org/0000-0001-6962-2893, Walton, Matthew orcid.org/0000-0003-1932-3689, Biswas, Mousumi orcid.org/0000-0001-6781-7400 et al. (2 more authors) (2017) Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy : An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1-12. ISSN 1179-2027

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Springer International Publishing AG, part of Springer Nature 2017. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.
Keywords: Journal Article
Dates:
  • Published (online): 30 November 2017
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
Depositing User: Pure (York)
Date Deposited: 05 Dec 2017 16:40
Last Modified: 14 Nov 2019 12:03
Published Version: https://doi.org/10.1007/s40273-017-0593-2
Status: Published online
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-017-0593-2

Download

Filename: PE_Review_Article_clean_revision.docx

Description: PE Review Article clean revision

Share / Export

Statistics